Clinical Trials Logo
  1. Home
  2. Respiratory Infection
  3. NCT05670678

Improved Respiratory Infection by Consuming Lactoferrin Fortified a2 Growing up Formula in Children of 2 to 3 Year Old

Respiratory Infection Clinical Trial

Official title:
Improved Respiratory Infection Outcomes Associated With Lactoferrin Fortified a2 Growing up Formula Consumption in Children of 2 to 3 Year Old: a Randomized, Open Label Trial

Clinical Trial Summary

The goal of this observational study is to compare the incidence of ARI and/or diarrheal disease associated with feeding different formulas with and without lactoferrin supplement in children of 2-3 years old. 200 children eligible for the study will be enrolled from two study sites and randomly assigned to two groups (a2 growing up stage 3 formula puls lactoferrin supplement, and Enfinitas growing up stage 3 formula) to feed for 90 days. About 160 children (80 for each group) are expected to finish the study, and data will be collected during the four visits across the study. Researchers will compare the two groups to see if there is significant decrease of the occurrence of diarrheal disease and/or acute respiratory infection for children fed with a2 growing up stage 3 formula puls lactoferrin supplement

Clinical Trial Description

This study is two arms, opening parallel-designed, observational study. Diarrheal and infectious episodes, including acute upper and lower respiratory infections (ARI), changes in stool patterns, use of systemic antibiotics, adverse events and study formula consumption will be compared in children 2 - 3 years of age who are assigned to receive one of the two following study formulas for a 3-month feeding period: a2 growing up stage 3 formula puls lactoferrin supplement and Enfinitas growingup stage 3 formula. 200 children eligible for the study will be enrolled from two study sites and randomly assigned to two groups to feed for 90 days. About 160 children (80 for each group) are expected to finish the study, and data of primary and secondary outcomes will be collected during the four visits across the study. A sample size of 80 completed per group is needed to achieve a 80% power. The Andersen-Gill model will be used to model the primary outcome (recurrent event of either diarrheal disease or an acute respiratory infection) under the framework of the proportional hazard assumption. For other secondary outcomes such as duration of acute respiratory infections(ARI) and/or diarrheal disease, episodes of systemic antibiotic use,amount of study formula consumed,changes in stool pattern and cost of treatment will also be analyzed. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05670678
Study type Observational
Source a2 Milk Company Ltd.
Contact
Status Completed
Phase
Start date December 19, 2022
Completion date May 17, 2023
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05359770 - Association of Inspiratory Muscle Training With HD-tDCS for Assistance to Patients With Long Covid-19 N/A
Recruiting NCT02989051 - Fluid Restriction Keeps Children Dry Phase 2/Phase 3
Withdrawn NCT00800696 - Preventive Oral Care N/A
Completed NCT01009619 - Azithromycin in Bronchiolitis Obliterans Syndrome Phase 4
Completed NCT04102644 - Limiting Adverse Birth Outcomes in Resource-Limited Settings
Not yet recruiting NCT05047666 - COVID-Like Illness Respiratory Pathogens. A Prospective Cohort on the COVID-19 Post-acute Condition
Active, not recruiting NCT00969800 - Test of a Preventive Effect of a Deodorant Device Against Respiratory Infections N/A
Completed NCT05683951 - Clinical Trial to Evaluate the Efficacy and Safety of DWKH Phase 3
Withdrawn NCT02981550 - Infection Detection by Breath Analysis N/A
Completed NCT03064659 - Driving Pressure And EFL in Adult Cardiac Surgery N/A
Recruiting NCT05860387 - Early Diagnosis of Invasive Lung Aspergillosis
Completed NCT03726853 - The Clinical Trial to Evaluate the Efficacy and Safety of CKD-497 Phase 2
Completed NCT01102374 - Vitamin D Supplementation and Acute Respiratory Infection in Older Long-Term Care Residents Phase 2
Completed NCT00758914 - Vitamin E and Infection in the Elderly N/A
Recruiting NCT05904223 - Effect of IN Hospital PCR Based Assessment of Patients With Lower Respiratory Tract Infections on LEngth of Stay N/A
Recruiting NCT06390878 - Nationwide Research on the Rewilding of Kindergarten Yards N/A
Completed NCT03540706 - Impact of the Use of CRP on the Prescription of Antibiotics in General Practitioners N/A
Completed NCT04318691 - Netosis in Determination of Respiratory Infection Severity
Recruiting NCT04581486 - Effectiveness of an Optimal-Massive Intervention in Older Patients With Dysphagia N/A
Completed NCT01967628 - Human Lung Responses to Respiratory Pathogens Phase 1/Phase 2